<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="659">
  <stage>Registered</stage>
  <submitdate>29/08/2005</submitdate>
  <approvaldate>29/08/2005</approvaldate>
  <nctid>NCT00138814</nctid>
  <trial_identification>
    <studytitle>Boost Use in Breast Conservation Radiotherapy</studytitle>
    <scientifictitle>A Randomised Comparison of Breast Conservation With or Without Lumpectomy Radiotherapy Boost</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>96/84 Graham</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Breast Neoplasms</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Breast</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Radiotherapy (boost versus no boost)

Treatment: surgery: Radiotherapy (boost versus no boost)


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Local failure of breast cancer at 72 month median follow-up and 10 year median follow-up for final analysis</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Local control translating to survival over 10 year median follow-up</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of life at yearly intervals with reference to baseline</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Breast cosmesis - patient assessment and photos</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Histologically proven carcinoma of the breast, T1-2 (0-5cm) N0-1, M0.

          -  Pure ductal carcinoma in situ accepted if completely excised.

          -  Any receptor status.

          -  Extensive intraductal cancer (EIC) accepted if completely excised.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Female</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Unable to consent

          -  Vascular/collagen disorder

          -  Prior malignancy except minor skin squamous cell or basal cell carcinoma or carcinoma
             in-situ of the cervix .

          -  Gross multifocal disease

          -  Involvement of margins.

          -  Bilateral breast cancer</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/01/1997</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Liverpool Hospital - Sydney</hospital>
    <hospital>Cancer Care Centre, St George Hospital - Sydney</hospital>
    <hospital>Wollongong Hospital - Wollongong</hospital>
    <postcode>2170 - Sydney</postcode>
    <postcode>2217 - Sydney</postcode>
    <postcode>2500 - Wollongong</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>St George Hospital, Australia</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a two arm randomized study for patients who are undergoing radiotherapy following
      breast conservation surgery for breast cancer. Local recurrence of breast cancer will be
      compared for patients receiving boost or no boost radiotherapy.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00138814</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Prof. Peter H Graham, MBBS FRANZCR</name>
      <address>Cancer Care Centre, St George Hospital, Sydney, Australia</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Associate Prof. Peter H Graham, MBBS FRANZCR</name>
      <address />
      <phone>+61 29350 3912</phone>
      <fax />
      <email>GrahamP@sesahs.nsw.gov.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>